Carvedilol

Product manufactured by Direct_rx

Application Nr Approved Date Route Status External Links
ANDA078332 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1.1 Heart Failure Carvedilol Tablets Are Indicated For The Treatment Of Mild-To-Severe Chronic Heart Failure Of Ischemic Or Cardiomyopathic Origin, Usually In Addition To Diuretics, Ace Inhibitors, And Digitalis, To Increase Survival And, Also, To Reduce The Risk Of Hospitalization [see Drug Interactions (7.4), Clinical Studies (14.1)]. 1.2 Left Ventricular Dysfunction Following Myocardial Infarction Carvedilol Tablets Are Indicated To Reduce Cardiovascular Mortality In Clinically Stable Patients Who Have Survived The Acute Phase Of A Myocardial Infarction And Have A Left Ventricular Ejection Fraction Of Less Than Or Equal To 40% (with Or Without Symptomatic Heart Failure) [see Clinical Studies (14.2)]. 1.3 Hypertension Carvedilol Tablets Are Indicated For The Management Of Essential Hypertension [see Clinical Studies (14.3, 14.4)]. It Can Be Used Alone Or In Combination With Other Antihypertensive Agents, Especially Thiazide-Type Diuretics [see Drug Interactions (7.2)].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Carvedilol CARVEDILOL ZINC1530579

Comments